Key Ingredients
Repaglinide 1 mg enhances insulin secretion to manage post-meal glucose levels, while Metformin 500 mg reduces hepatic glucose production and improves insulin utilization, together supporting comprehensive glycemic control.
Benefits
Controls Post-Meal Blood Sugar: Helps prevent sharp rises in blood glucose after meals.
Improves Fasting Glucose Levels: Supports better baseline blood sugar control.
Dual-Mechanism Action: Combines insulin secretion support with improved insulin sensitivity.
Reduces Risk of Diabetic Complications: Supports long-term metabolic and vascular health.
Clinically Proven Combination Therapy: Widely prescribed under medical supervision for type 2 diabetes management.
Usage Instructions
Take the tablet exactly as prescribed by a healthcare professional, usually before meals. Regular monitoring of blood glucose levels is recommended.
Side Effects
May include low blood sugar, nausea, stomach upset, dizziness, or headache. Consult a healthcare provider if side effects persist or worsen.
General Information
- Form: Tablet
- Strength: 1 mg + 500 mg
- Composition: Repaglinide 1 mg + Metformin 500 mg
- Brand: Ripadep Plus 1
- Packaging Size: 1 × 10 Tablets
- Packaging Type: Strip
- Shelf Life: 24 Months
- Indications: Type 2 diabetes mellitus
- Prescription Status: Prescription Drug
- Availability: In Stock
- Also Available As: PCD Pharma Franchise
- Country of Origin: India
Globus Labs brings you WHO-GMP–certified, high-quality Repaglinide 1 mg & Metformin 500 mg Tablets IP sourced from reputed pharmaceutical manufacturers. Ripadep Plus 1 is formulated to deliver safe, potent, and clinically trusted support.
